Skip to Content
New To Chronic Myeloid Leukemia? Get Information Today >>

Bleomycin Pregnancy and Breastfeeding Warnings

Bleomycin is also known as: Blenoxane

Bleomycin Pregnancy Warnings

Bleomycin has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of teratogenicity (e.g., skeletal malformations) in rats. There are no controlled data in human pregnancy; however, use of bleomycin during pregnancy has been associated with fetal harm. If bleomycin is used during pregnancy or if the patient becomes pregnant during treatment, the patient should be advised of the potential hazard to the developing fetus. Women of childbearing potential should be advised to avoid pregnancy during treatment with bleomycin.

See references

Bleomycin Breastfeeding Warnings

There are no data on the excretion of bleomycin into human milk.

See references

References for pregnancy information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. American Medical Association, Division of Toxicology. "Drug Evaluation Annual 1995." Chicago, IL: American Medical Association (1995):
  3. "Product Information. Blenoxane (bleomycin)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
  2. "Product Information. Blenoxane (bleomycin)." Bristol-Myers Squibb, Princeton, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.